Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination

Journal of Leukocyte Biology

Volumn 80, Issue 6, 2006, Pages 1262-1271

  Flaherty, David K ^a   Vesosky, Bridget ^a   Beamer, Gillian L ^a   Stromberg, Paul ^a   Turner, Joanne ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Environmental mycobacteria; Interference; Murine; Tuberculosis

Indexed keywords

BCG VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; GRANULOMA; IMMUNITY; INFECTION CONTROL; LUNG ALVEOLUS CELL; LYMPH NODE; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TUBERCULOSIS; VACCINATION;

ANIMALS; BCG VACCINE; BRONCHI; FEMALE; HUMANS; INFANT; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; MYCOBACTERIUM AVIUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; T-LYMPHOCYTES; TUBERCULOSIS, PULMONARY;

BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; MURINAE; MYCOBACTERIUM AVIUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS;

EID: 33845455460     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0606407     Document Type: Article

References (42)

1. Corbett, E. L., Watt, C. J., Walker, N., Maher, D., Williams, B. G., Raviglione, M. C., Dye, C. (2003) The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch. Intern. Med. 163, 1009-1021.
2. Kochi, A. (1991) The global tuberculosis situation and the new control strategy of the World Health Organization. Tubercle 72, 1-6.
3. World Health Organization (2006) Global tuberculosis surveillance, planning, financing. WHO, Geneva. 1-250.
4. World Health Organization (2005) WHO Vaccine-Preventable Diseases: Monitoring System. WHO, Geneva. 1-333.
5. Fine, P. E. M. (1994) Immunities in and to tuberculosis: implications for pathogenesis and vaccination. In Tuberculosis: Back to the Future (J. D. H. Porter, K. P. W. J. McAdam, eds.), Australia, John Wiley & Sons Ltd., 53-71.
6. Fine, P. E. (2001) BCG: the challenge continues. Scand. J. Infect. Dis. 33, 243-245.
7. Smith, D., Wiegeshaus, E., Balasubramanian, V. (2000) An analysis of some hypotheses related to the Chingelput bacille Calmette-Guerin trial. Clin. Infect. Dis. 31 (Suppl. 3), S77-S80.
8. Brandt, L., Feino Cunha, J., Weinreich Olsen, A., Chilima, B., Hirsch, P., Appelberg, R., Andersen, P. (2002) Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect. Immun. 70, 672-678.
9. de Lisle, G. W., Wards, B. J., Buddle, B. M., Collins, D. M. (2005) The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium. Tuberculosis (Edinb.) 85, 73-79.
10. Buddle, B. M., Wards, B. J., Aldwell, F. E., Collins, D. M., de Lisle, G. W. (2002) Influence of sensitization to environmental mycobacteria on subsequent vaccination against bovine tuberculosis. Vaccine 20, 1126-1133.
11. Palmer, C. E., Long, M. W. (1966) Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis. Am. Rev. Respir. Dis. 94, 553-568.
12. Fine, P. E. (1989) The BCG story: lessons from the past and implications for the future. Rev. Infect. Dis. 11 (Suppl. 2), S353-S359.
13. Howard, C. J., Kwong, L. S., Villarreal-Ramos, B., Sopp, P., Hope, J. C. (2002) Exposure to Mycobacterium avium primes the immune system of calves for vaccination with Mycobacterium bovis BCG. Clin. Exp. Immunol. 130, 190-195.
14. World Health Organization (2006) Immunization Surveillance, Assessment and Monitoring. Vaccine-preventable diseases: tuberculosis. WHO, Geneva. 1.
15. hi population. Infect. Immun. 73, 7759-7764.
16. Brooks, J. V., Frank, A. A., Keen, M. A., Belisle, J. T., Orme, I. M. (2001) Boosting vaccine for tuberculosis. Infect. Immun. 69, 2714-2717.
17. Demangel, C., Garnier, T., Rosenkrands, I., Cole, S. T. (2005) Differential effects of prior exposure to environmental mycobacteria on vaccination with Mycobacterium bovis BCG or a recombinant BCG strain expressing RD1 antigens. Infect. Immun. 73, 2190-2196.
18. Primm, T. P., Lucero, C. A., Falkinham III, J. O. (2004) Health impacts of environmental mycobacteria. Clin. Microbiol. Rev. 17, 98-106.
19. Torrelles, J. B., Ellis, D., Osborne, T., Hoefer, A., Orme, I. M., Chatterjee, D., Brennan, P. J., Cooper, A. M. (2002) Characterization of virulence, colony morphotype and the glycopeptidolipid of Mycobacterium avium strain 104. Tuberculosis (Edinb.) 82, 293-300.
20. Saunders, B. M., Frank, A. A., Cooper, A. M., Orme, I. M. (1998) Role of γ δ T cells in immunopathology of pulmonary Mycobacterium avium infection in mice. Infect. Immun. 66, 5508-5514.
21. Saunders, B. M., Dane, A., Briscoe, H., Britton, W. J. (2002) Characterization of immune responses during infection with Mycobacterium avium strains 100, 101 and the recently sequenced 104. Immunol. Cell Biol. 80, 544-549.
22. Sangari, F. J., Goodman, J., Petrofsky, M., Kolonoski, P., Bermudez, L. E. (2001) Mycobacterium avium invades the intestinal mucosa primarily by interacting with enterocytes. Infect. Immun. 69, 1515-1520.
23. Bermudez, L. E., Parker, A., Petrofsky, M. (1999) Apoptosis of Mycobacterium avium-infected macrophages is mediated by both tumor necrosis factor (TNF) and Fas, and involves the activation of caspases. Clin. Exp. Immunol. 116, 94-99.
24. + T cells during experimental infection with Mycobacterium avium is controlled by Fas/FasL and Bcl-2-sensitive pathways, respectively. Immunol. Cell Biol. 81, 480-486.
25. + lymphocytes for apoptosis upon exposure to macrophages. Clin. Immunol. 99, 378-386.
26. Martino, A., Sacchi, A., Volpe, E., Agrati, C., De Santis, R., Pucillo, L. P., Colizzi, V., Vendetti, S. (2005) Non-pathogenic Mycobacterium smegmatis induces the differentiation of human monocytes directly into fully mature dendritic cells. J. Clin. Immunol. 25, 365-375.
27. Bermudez, L. E., Champsi, J. (1993) Infection with Mycobacterium avium induces production of interleukin-10 (IL-10), and administration of anti-IL-10 antibody is associated with enhanced resistance to infection in mice. Infect. Immun. 61, 3093-3097.
28. Balcewicz-Sablinska, M. K., Gan, H., Remold, H. G. (1999) Interleukin 10 produced by macrophages inoculated with Mycobacterium avium attenuates mycobacteria-induced apoptosis by reduction of TNF-α activity. J. Infect. Dis. 180, 1230-1237.
29. Silva, R. A., Pais, T. F., Appelberg, R. (2001) Blocking the receptor for IL-10 improves antimycobacterial chemotherapy and vaccination. J. Immunol. 167, 1535-1541.
30. Wagner, D., Sangari, F. J., Kim, S., Petrofsky, M., Bermudez, L. E. (2002) Mycobacterium avium infection of macrophages results in progressive suppression of interleukin-12 production in vitro and in vivo. J. Leukoc. Biol. 71, 80-88.
31. Sangari, F. J., Petrofsky, M., Bermudez, L. E. (1999) Mycobacterium avium infection of epithelial cells results in inhibition or delay in the release of interleukin-8 and RANTES. Infect. Immun. 67, 5069-5075.
32. Tsuyuguchi, I., Kawasumi, H., Takashima, T., Tsuyuguchi, T., Kishimoto, S. (1990) Mycobacterium avium-Mycobacterium intracellulare complex-induced suppression of T-cell proliferation in vitro by regulation of monocyte accessory cell activity. Infect. Immun. 58, 1369-1378.
33. Gagliardi, M. C., Teloni, R., Giannoni, F., Pardini, M., Sargentini, V., Brunori, L., Fattorini, L., Nisini, R. (2005) Mycobacterium bovis Bacillus Calmette-Guerin infects DC-SIGN-dendritic cell and causes the inhibition of IL-12 and the enhancement of IL-10 production. J. Leukoc. Biol. 78, 106-113.
34. Hubeau, C., Singer, M., Lagranderie, M., Marchal, G., Vargaftig, B. (2003) Extended freeze-dried Mycobacterium bovis Bacillus Calmette-Guerin induces the release of interleukin-12 but not tumor necrosis factor-α by alveolar macrophages, both in vitro and in vivo. Clin. Exp. Allergy 33, 386-393.
35. Matsumoto, H., Suzuki, K., Tsuyuguchi, K., Tanaka, E., Amitani, R., Maeda, A., Yamamoto, K., Sasada, M., Kuze, F. (1997) Interleukin-12 gene expression in human monocyte-derived macrophages stimulated with Mycobacterium bovis BCG: cytokine regulation and effect of NK cells. Infect. Immun. 65, 4405-4410.
36. + lymphocytes are required for host protection against Mycobacterium avium infection and dissemination through the intestinal route. Infect. Immun. 73, 2621-2627.
37. Weir, R. E., Fine, P. E., Nazareth, B., Floyd, S., Black, G. F., King, E., Stanley, C., Bliss, L., Branson, K., Dockrell, H. M. (2003) Interferon-γ and skin test responses of schoolchildren in Southeast England to purified protein derivatives from Mycobacterium tuberculosis and other species of mycobacteria. Clin. Exp. Immunol. 134, 285-294.
38. Fine, P. E., Floyd, S., Stanford, J. L., Nkhosa, P., Kasunga, A., Chaguluka, S., Warndorff, D. K., Jenkins, P. A., Yates, M., Ponnighaus, J. M. (2001) Environmental mycobacteria in Northern Malawi: implications for the epidemiology of tuberculosis and leprosy. Epidemiol. Infect. 126, 379-387.
39. Inderlied, C. B., Kemper, C. A., Bermudez, L. E. (1993) The Mycobacterium avium complex. Clin. Microbiol. Rev. 6, 266-310.
40. Black, G. F., Dockrell, H. M., Crampin, A. C., Floyd, S., Weir, R. E., Bliss, L., Sichali, L., Mwaungulu, L., Kanyongoloka, H., Ngwira, B., Warndorff, D. K., Fine, P. E. (2001) Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in Northern Malawi. J. Infect. Dis. 184, 322-329.
41. Kroger, L., Korppi, M., Pelkonen, J., Pietikainen, M., Katila, M. L. (2000) Development of tuberculin reactivity and sensitization to M. scrofulaceum and M. fortuitum in children BCG-vaccinated at birth. Eur. Respir. J. 15, 382-387.
42. Huang, J. H., Kao, P. N., Adi, V., Ruoss, S. J. (1999) Mycobacterium avium-intracellulare pulmonary infection in HIV-negative patients without preexisting lung disease: diagnostic and management limitations. Chest 115, 1033-1040.